Rheinhessen-Fachklinik Mainz
- Address
- Hartmühlenweg 2-4, 55122 Mainz, Germany
Rheinhessen-Fachklinik Mainz
Rheinhessen-Fachklinik Mainz is a specialized medical research center with significant expertise in pediatric and adolescent psychiatry, particularly in the evaluation of pharmacological treatments for neurodevelopmental disorders. The facility conducts sophisticated clinical trials examining both the safety and efficacy of novel therapeutic interventions in younger patient populations.
- Attention-Deficit/Hyperactivity Disorder (ADHD) treatment research in children and adolescents aged 6 to 17 years
- Comparative safety studies of non-stimulant ADHD medications including guanfacine and atomoxetine
- Neurocognitive assessment using advanced neuropsychological testing methodologies
The center demonstrates particular strength in conducting long-term safety evaluations of psychiatric medications, with focus on patients for whom stimulant treatments are not suitable or effective. Their research incorporates sophisticated assessment tools such as the Cambridge Automated Neuropsychological Test Battery (CANTAB) to measure treatment effects on psychomotor speed, attention, and cognitive function, representing a comprehensive approach to understanding both therapeutic benefits and safety profiles in pediatric psychopharmacology.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Rheinhessen-Fachklinik Mainz
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 4, Multicenter, 2-part Study Composed of a Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation followed by a Open-label Evaluation to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged-release (SPD503) in Children and Adolescents aged 6 to 17 Years with Attention-deficit/Hyperactivity Disorder | Takeda Development Center Americas Inc. | Phase III | Not Recruiting | Nov 2019 | Sep 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atomoxetine Hydrochloride | 1 | Unknown | 2019-11-20 | 2019-11-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.